CCL2 and breast carcinoma: Based on these data, we hypothesize that ASS1 expression restores arginine metabolism in M231-ADIR cells, whereas TREM1 expression stimulates AKT/mTOR/STAT3 and a CCL2 feed-forward loop to provide survival signals contributing to ADI resistance in breast cancer cells (Figure 6B).